Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Magazine

Table: Better Antibiotics


What's needed to get drug companies to make the necessary compounds:

REWARD DISCOVERY

Create more partnerships between the government and drug companies, with public funding for promising early-stage research.

DON'T OVER-REGULATE

Scrutinize all new FDA rules to make sure they don't discourage spending on antibiotics R&D in the future.

IMPROVE THE ECONOMICS

When new antibiotics must be used sparingly to fight drug-resistant bugs, extend patent life to compensate companies and encourage them to invest in the future.

PROTECT THE PATENTS

Avoid violating the patents on essential drugs such as Cipro. Such violations should only be sanctioned if supplies are inadequate and alternatives don't exist.


LIMITED-TIME OFFER SUBSCRIBE NOW
 
blog comments powered by Disqus